News Releases Year None20242023202220212020201920182017 NuCana to Participate in Citi's 17th Annual BioPharma Conference Aug 31, 2022 NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update Aug 17, 2022 NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement Jul 27, 2022 German Court Rules that Gilead’s Sofosbuvir Infringes NuCana’s ‘190 Patent Jul 11, 2022 NuCana Announces Presentation on NUC-7738 at the European Hematology Association (EHA) 2022 Hybrid Congress Jun 10, 2022 NuCana Announces Receipt of NASDAQ Notice Jun 03, 2022 NuCana Reports First Quarter 2022 Financial Results and Provides Business Update Jun 02, 2022 NuCana to Participate in the 2022 Jefferies Healthcare Conference Jun 01, 2022 NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update Apr 27, 2022 NuCana Announces Upcoming Presentations on NUC-3373 at the American Association for Cancer Research (AACR) Annual Meeting 2022 Mar 08, 2022 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
NuCana Announces Presentation on NUC-7738 at the European Hematology Association (EHA) 2022 Hybrid Congress Jun 10, 2022
NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update Apr 27, 2022
NuCana Announces Upcoming Presentations on NUC-3373 at the American Association for Cancer Research (AACR) Annual Meeting 2022 Mar 08, 2022